Skip to main content

Table 2 Prevalence of antibiotics resistance among MRSA and MSSA strains from the two groups of lesions

From: Methicillin-resistant Staphylococcus aureus colonization of infectious and non-infectious skin and soft tissue lesions in patients in Tehran

MRSA

MSSA

 

Infectious Group

N = 16

Non-infectious Group

N = 43

χ2, P-Value

Total

N = 59

Infectious Group

N = 14

Non-infectious Group

N = 32

χ2, P- Value

Total

N = 46

L

3(18.7%)

8(32%)

.990

11(18.6%)

2(14.2%)

4(12.5%)

.869

6(13.3%)

Mu

1(6.2%)

12(27.9%)

.074

13(22%)

3(21.4%)

6(18.7%)

.833

9(19.5%)

C

0

2(4.6%)

.278

2(3.3%)

0

0

0

AK

2(12.5%)

8(18.6%)

.578

10(16.9%)

0

1(3.1%)

.504

1(2.1%)

T

8(50%)

13(30.2%)

.159

21(35.5%)

5(35.7%)

8(25%)

.458

13(28.2%)

PG

16(100%)

39(90.6%)

.206

55(93.2%)

14(100%)

29(90.6%)

.236

43(93.4%)

CIP

2(12.5%)

3(6.9%)

.498

5(8.7%)

0

1(3.1%)

.504

1(2.1%)

GM

1(6.2%)

4(9.3%)

.708

5(8.7%)

0

0

0

SXT

7(43.7%)

10(23.2%)

.122

17(28.8%)

1(7.1%)

2(6.2%)

.910

3(6.5%)

E

8(50%)

16(37.2%)

.374

24(40.6%)

5(35.7%)

13(40.6%)

.754

18(39.1%)

CD

11(68.7%)

28(65.5%)

.793

37(62.7%)

2(14.2%)

9(28.1%)

.311

11(23.9%)

RA

6(37.5%)

15(34.8%)

.852

21(35.5%)

1(7.1%)

4(12.5%)

.591

5(10.8%)

  1. L linezolid, Mu mupirocin, C chloramphenicol, AK amikacin, FOX cefoxitin, T tetracycline, PG penicillin, CIP ciprofloxacin, GM gentamicin, SXT trimethoprim/sulfamethoxazole, E erythromycin, CD clindamycin, RA rifampin